Although clinical studies in pregnant women have not indicated that dimenhydrinate increases the risk of fetal abnormalities, like any drug, it should be used during pregnancy only if benefits outweigh the risks. As small amounts of dimenhydrinate are excreted in breast milk, benefits of therapy must be weighed against potential adverse reactions in nursing infants.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign Out
